HealthEquity, Inc. (NASDAQ:HQY) Shares Purchased by Inspire Investing LLC

Inspire Investing LLC grew its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 75.2% in the third quarter, Holdings Channel reports. The institutional investor owned 24,027 shares of the company’s stock after acquiring an additional 10,312 shares during the quarter. Inspire Investing LLC’s holdings in HealthEquity were worth $1,967,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Motley Fool Asset Management LLC grew its position in shares of HealthEquity by 3,001.0% in the first quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company’s stock valued at $307,097,000 after purchasing an additional 3,640,748 shares in the last quarter. Vaughan Nelson Investment Management L.P. acquired a new stake in shares of HealthEquity in the 1st quarter worth $49,443,000. Wasatch Advisors LP raised its holdings in shares of HealthEquity by 8.3% during the 1st quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company’s stock worth $604,803,000 after acquiring an additional 569,249 shares during the period. Mackenzie Financial Corp boosted its position in shares of HealthEquity by 16.0% during the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after acquiring an additional 325,906 shares during the last quarter. Finally, Generate Investment Management Ltd purchased a new stake in shares of HealthEquity in the second quarter valued at about $24,184,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Stock Performance

Shares of HQY stock opened at $85.42 on Monday. The firm has a 50 day moving average of $77.14 and a two-hundred day moving average of $79.28. The stock has a market capitalization of $7.43 billion, a PE ratio of 92.85, a P/E/G ratio of 1.31 and a beta of 0.52. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 52 week low of $61.81 and a 52 week high of $88.26.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The firm had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. On average, research analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently issued reports on HQY shares. Barrington Research restated an “outperform” rating and set a $105.00 price target on shares of HealthEquity in a report on Friday, September 20th. Wells Fargo & Company lifted their target price on HealthEquity from $107.00 to $110.00 and gave the company an “overweight” rating in a research report on Thursday, June 20th. JMP Securities reiterated a “market outperform” rating and set a $105.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Bank of America reduced their price objective on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $103.83.

Insider Activity

In related news, Director Frank Corvino sold 1,247 shares of the company’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the sale, the director now directly owns 4,823 shares in the company, valued at approximately $387,093.98. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares of the company’s stock, valued at $4,540,582.62. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Frank Corvino sold 1,247 shares of the stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the completion of the transaction, the director now owns 4,823 shares in the company, valued at approximately $387,093.98. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 44,497 shares of company stock worth $3,579,769. 2.20% of the stock is currently owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.